Morikawa Y - Search Results

1

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

Arai H, Ishiguro K, Ohno H, Moriyama M, Itoh N, Okamura N, Matsui T, Morikawa Y, Horikawa E, Kohno H, Sasaki H, Imahori K. Arai H, et al. Among authors: morikawa y. Exp Neurol. 2000 Nov;166(1):201-3. doi: 10.1006/exnr.2000.7501. Exp Neurol. 2000. PMID: 11031097

2

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.

Arai H, Morikawa Y, Higuchi M, Matsui T, Clark CM, Miura M, Machida N, Lee VM, Trojanowski JQ, Sasaki H. Arai H, et al. Among authors: morikawa y. Biochem Biophys Res Commun. 1997 Jul 18;236(2):262-4. doi: 10.1006/bbrc.1997.6908. Biochem Biophys Res Commun. 1997. PMID: 9240421 Free article.

3

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

Arai H, Satoh-Nakagawa T, Higuchi M, Morikawa Y, Miura M, Kawakami H, Seki H, Takase S, Sasaki H. Arai H, et al. Among authors: morikawa y. Neurosci Lett. 1998 Nov 13;256(3):174-6. doi: 10.1016/s0304-3940(98)00781-2. Neurosci Lett. 1998. PMID: 9855368 Clinical Trial.

4

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

Morikawa Y, Arai H, Matsushita S, Kato M, Higuchi S, Miura M, Kawakami H, Higuchi M, Okamura N, Tashiro M, Matsui T, Sasaki H. Morikawa Y, et al. Alcohol Clin Exp Res. 1999 Apr;23(4):575-7. Alcohol Clin Exp Res. 1999. PMID: 10235290

5

Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese.

Matsui T, Morikawa Y, Tojo M, Okamura N, Maruyama M, Hirai H, Chiba H, Matsushita S, Higuchi S, Arai H, Sasaki H. Matsui T, et al. Among authors: morikawa y. Ann Neurol. 2001 Apr;49(4):544-5. Ann Neurol. 2001. PMID: 11310638 No abstract available.

6

Studies on 15-hydroxyprostaglandin dehydrogenase with various prostaglandin analogues.

Ohno H, Morikawa Y, Hirata F. Ohno H, et al. Among authors: morikawa y. J Biochem. 1978 Dec;84(6):1485-94. doi: 10.1093/oxfordjournals.jbchem.a132272. J Biochem. 1978. PMID: 216666 Free article.

7

Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene.

Miura M, Yamagishi H, Morikawa Y, Matsuoka R. Miura M, et al. Among authors: morikawa y. Pediatr Cardiol. 2003 Jan-Feb;24(1):70-2. doi: 10.1007/s00246-002-0169-5. Pediatr Cardiol. 2003. PMID: 12574983

8

Efficacy of live attenuated vaccines after two doses of intravenous immunoglobulin for Kawasaki disease.

Morikawa Y, Sakakibara H, Miura M. Morikawa Y, et al. World J Pediatr. 2022 Oct;18(10):706-709. doi: 10.1007/s12519-022-00594-6. Epub 2022 Aug 11. World J Pediatr. 2022. PMID: 35953691 No abstract available.

9

Hyperpolarization is not responsible for the acetylcholine-induced negative chronotropic action in the presence of isoproterenol.

Miura M, Furuta T, Ueda H, Yamada K, Tachi K, Kasai H, Morikawa Y. Miura M, et al. Among authors: morikawa y. Basic Res Cardiol. 2000 Dec;95(6):442-8. doi: 10.1007/s003950070019. Basic Res Cardiol. 2000. PMID: 11192364

10

Necrotizing tracheobronchitis in patent ductus arteriosus-dependent cyanotic congenital heart disease.

Nakata Y, Morikawa Y, Miura M, Kawasaki K, Toyoma H, Kameyama K. Nakata Y, et al. Among authors: morikawa y. Pediatr Pulmonol. 2001 Dec;32(6):480-3. doi: 10.1002/ppul.1162. Pediatr Pulmonol. 2001. PMID: 11747253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,063 results

Search Page

Filters